Chronic Obstructive Pulmonary Disease (COPD): Causes, Diagnosis, GOLD Classification & Treatment

Chronic Obstructive Pulmonary Disease, or COPD, is a progressive respiratory condition that results in airflow obstruction due to damage and inflammation in the lungs. This post explores the causes, clinical features, diagnostic strategies, and up-to-date management of COPD based on the latest GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines.


🔍 What Is COPD?

COPD is a chronic obstructive pulmonary disease marked by irreversible airflow obstruction. It occurs due to a combination of:

  • Small airway obstruction
  • Parenchymal (alveolar) destruction

This obstructive pattern leads to difficulty in exhaling air out of the lungs.

COPD vs Asthma

  • Asthma = Reversible airflow obstruction
  • COPD = Irreversible airflow obstruction

🔬 Types of COPD

COPD comprises two overlapping conditions:

1. Chronic Bronchitis

Defined as a productive cough lasting for at least 3 months per year for 2 consecutive years. Caused mainly by:

  • Smoking-induced damage
  • Mucus hypersecretion
  • Bronchial obstruction

2. Emphysema

Characterized by destruction of alveoli and enlargement of airspaces distal to terminal bronchioles. This leads to poor gas exchange and breathlessness.

🔸 In practice, most COPD patients have features of both conditions.


⚠️ Causes of COPD

Exogenous Causes

  • Smoking (90% of cases)
  • Air pollution
  • Occupational exposure (coal, silica, fumes)
  • Indoor biomass fuel (wood, animal dung)

Endogenous Causes

  • Alpha-1 Antitrypsin Deficiency (in young non-smokers)
  • IgA deficiency
  • Kartagener syndrome

📊 GOLD Classification of COPD

COPD severity is classified using:

  • Spirometry: Measures FEV₁ (Forced Expiratory Volume in 1 second)
  • CAT Score: COPD Assessment Test (symptom-based)
  • mMRC Dyspnea Scale: Based on breathlessness during activities
  • Exacerbation Frequency: Number of flare-ups per year

Spirometry-Based GOLD Grades

GOLD GradeSeverityFEV₁ % Predicted
GOLD 1Mild≥ 80%
GOLD 2Moderate50–79%
GOLD 3Severe30–49%
GOLD 4Very Severe< 30%

🧪 Clinical Features of COPD

  • Chronic productive cough (especially in chronic bronchitis)
  • Dyspnea (initially exertional, then at rest)
  • Pursed-lip breathing
  • Tripod position (leaning forward with hands on knees)
  • Prolonged expiration
  • Barrel-shaped chest
  • Wheezing and decreased breath sounds

🔎 Diagnostic Workup

1. Spirometry

  • Diagnostic gold standard
  • FEV₁/FVC ratio < 70%
  • FEV₁ predicts severity

2. DLCO (Diffusion Test)

  • Normal in chronic bronchitis
  • ↓ in emphysema due to alveolar destruction

3. Chest X-ray

  • Hyperinflated lungs
  • Flattened diaphragm
  • Tubular heart
  • Increased AP diameter (barrel chest)

4. ABGs (Arterial Blood Gases)

  • Indicated in severe cases or exacerbations
  • Reveals hypoxia and/or hypercapnia

5. Alpha-1 Antitrypsin Testing

  • Especially in young, non-smoker patients

6. CBC

  • Elevated hematocrit due to chronic hypoxia

💊 Treatment of Stable COPD

🔸 Short-Acting Bronchodilators (SABAs)

  • Albuterol (90 mcg per puff): Used 4–6 hourly PRN

🔸 Long-Acting Bronchodilators (LABAs)

  • Salmeterol (50 mcg BID)
  • Preferred in moderate to severe COPD

🔸 Long-Acting Muscarinic Antagonists (LAMAs)

  • Tiotropium (18 mcg OD)
  • Improve symptoms and reduce exacerbations

🔸 Inhaled Corticosteroids (ICS)

  • Used in combination with LABA or LAMA for frequent exacerbators (Group C or D)

🔸 Antibiotic Prophylaxis

  • Azithromycin may reduce exacerbation risk

🌬️ Long-Term Oxygen Therapy (LTOT)

  • Indicated when O₂ saturation ≤ 88%
  • Target O₂ saturation: 90–93%
  • Improves survival in hypoxemic patients

⚠️ Never give 100% oxygen — risk of respiratory depression due to CO₂ retention.


🧪 Additional Therapies

  • Mucolytics: N-acetylcysteine to loosen mucus
  • Theophylline: Reserved for refractory cases
  • Surgery: Lung volume reduction, bullectomy, or lung transplant in advanced disease

💡 Preventive Measures

  • Smoking cessation: Most effective intervention to slow progression
  • Vaccinations:
    • Annual influenza vaccine
    • Pneumococcal vaccine (for all COPD patients, especially age >65)
  • Chest physiotherapy: Postural drainage for mucus clearance
  • Pulmonary rehab: Exercise training, education, nutritional advice

⚠️ Complications of COPD

  • Chronic respiratory failure
  • Cor pulmonale (right heart failure)
  • Recurrent infections
  • Spontaneous pneumothorax
  • Polycythemia due to chronic hypoxia

🧾 Summary

  • COPD is an irreversible obstructive airway disease caused by chronic exposure to toxins (mainly smoking).
  • Diagnosis is confirmed with spirometry (FEV₁/FVC < 70%).
  • GOLD classification helps guide treatment based on spirometry, symptoms, and exacerbation history.
  • Management includes bronchodilators, ICS, LTOT, smoking cessation, vaccinations, and rehab.
  • Only smoking cessation and long-term oxygen therapy have shown to reduce mortality.

Leave a Comment

Your email address will not be published. Required fields are marked *